A novel support material for 3D bioprinting and post-printing tissue growth: Print and Grow
The "Print and Grow" project aims to enhance 3D bioprinting stability and viability of tissue constructs through a novel microgel support, optimizing for diverse tissue types and in vivo applications.
Projectdetails
Introduction
Three-dimensional (3D) bioprinting holds great promise for tissue engineering, with extrusion bioprinting in suspended hydrogels becoming the leading bioprinting technique in recent years. In this method, living cells are incorporated within bioinks, extruded layer by layer into a granular support material, and undergo gelation through diverse cross-linking mechanisms.
Advantages and Challenges
It offers high fidelity and precise fabrication of complex structures based on the living tissue properties. However, the transition of cell mass mixed with the bioink into functional native-like tissue requires post-printing cultivation in vitro. An often-overlooked drawback of 3D bioprinting is the non-uniform shrinkage and deformation of printed constructs during the post-printing tissue maturation period. This leads to highly variable and unpredictable engineered constructs, posing a challenge for the technology to meet applicative requirements.
Proposed Solution
We propose to develop a novel technology of "Print and Grow," 3D bioprinting into a specially designed microgel aimed to enhance the long-term structural stability of the printed objects by providing structural support and a possibility for live monitoring during tissue maturation.
Preliminary Testing
Our preliminary testing of the “Print and Grow” method demonstrated accurate bioprinting with high tissue viability while preserving the construct shape and size, unlike current state-of-the-art approaches.
Future Plans
We aim to:
- Optimize the support material properties.
- Develop scalable and reproducible fabrication techniques.
- Test the “Print and Grow” for a wide range of tissue types and adjust the microgel according to specific tissue requirements.
Finally, we will study the in vivo transplantation possibility of the tissue generated through the “Print and Grow” process.
Conclusion
The results of our proof of concept project may lead to the emergence of universal and user-friendly 3D bioprinting technology for regenerative medicine, drug discovery, and the cultured meat industry.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-6-2022 |
Einddatum | 30-11-2023 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGYpenvoerder
Land(en)
Geen landeninformatie beschikbaar
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogelsmorphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth. | ERC Starting... | € 1.499.906 | 2023 | Details |
Jam with the flow: Microgel-based (bio)inks that assemble during printingDeveloping microgel-based materials for extrusion-based 3D printing to create stable, heterogeneous scaffolds with precise control over local properties for biomedical applications. | ERC Starting... | € 2.075.000 | 2025 | Details |
Human based bioinks to engineer physiologically relevant tissuesHumanINK aims to validate human-based bioinks for 3D bioprinting, creating advanced cell culture environments to enhance drug development and reduce reliance on animal testing. | ERC Proof of... | € 150.000 | 2022 | Details |
Bioactive reinforcing bioink for hybrid bioprinting of implantable boneThe project aims to develop 'BioForceInk,' a bioactive bioink for hybrid 3D bioprinting of vascularized bone implants, enhancing mechanical strength and biological functionality for clinical applications. | ERC Proof of... | € 150.000 | 2024 | Details |
Holographic Optical Tweezing Bioprinting (HOTB): Towards precise manipulation of cells for artificial multi-scaled vascularized tissues/organ printing.The HOT-BIOPRINTING project aims to revolutionize tissue engineering by developing a holographic optical tweezing bioprinter for high-resolution, automated 3D bioprinting of complex, vascularized tissues. | ERC Consolid... | € 1.965.525 | 2024 | Details |
4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels
morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.
Jam with the flow: Microgel-based (bio)inks that assemble during printing
Developing microgel-based materials for extrusion-based 3D printing to create stable, heterogeneous scaffolds with precise control over local properties for biomedical applications.
Human based bioinks to engineer physiologically relevant tissues
HumanINK aims to validate human-based bioinks for 3D bioprinting, creating advanced cell culture environments to enhance drug development and reduce reliance on animal testing.
Bioactive reinforcing bioink for hybrid bioprinting of implantable bone
The project aims to develop 'BioForceInk,' a bioactive bioink for hybrid 3D bioprinting of vascularized bone implants, enhancing mechanical strength and biological functionality for clinical applications.
Holographic Optical Tweezing Bioprinting (HOTB): Towards precise manipulation of cells for artificial multi-scaled vascularized tissues/organ printing.
The HOT-BIOPRINTING project aims to revolutionize tissue engineering by developing a holographic optical tweezing bioprinter for high-resolution, automated 3D bioprinting of complex, vascularized tissues.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
PRInted Symbiotic Materials as a dynamic platform for Living Tissues productionPRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications. | EIC Pathfinder | € 2.805.403 | 2022 | Details |
3D Printing of Ultra-fideLity tissues using Space for anti-ageing solutions on EarthThe project aims to develop a novel bioprinting technology in microgravity to create advanced cardiac models for studying ageing and drug efficacy, enhancing biofabrication and space research. | EIC Pathfinder | € 4.597.578 | 2023 | Details |
High-throughput ultrasound-based volumetric 3D printing for tissue engineeringSONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research. | EIC Pathfinder | € 2.999.625 | 2025 | Details |
Better Bioprinting by Light-sheet LithographyB-BRIGHTER aims to develop a novel high-speed bioprinting technology for creating complex engineered tissues, enhancing drug testing and therapeutic applications while fostering healthcare innovation. | EIC Transition | € 2.093.331 | 2022 | Details |
3D voedselprinters op weg naar industriële toepassingenHet project ontwikkelt een industriële 3D voedselprinter voor het produceren van hoogwaardige, gezonde en betaalbare vlees- en visvervangers met authentieke textuur en hoge productiesnelheid. | Mkb-innovati... | € 350.000 | 2023 | Details |
PRInted Symbiotic Materials as a dynamic platform for Living Tissues production
PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.
3D Printing of Ultra-fideLity tissues using Space for anti-ageing solutions on Earth
The project aims to develop a novel bioprinting technology in microgravity to create advanced cardiac models for studying ageing and drug efficacy, enhancing biofabrication and space research.
High-throughput ultrasound-based volumetric 3D printing for tissue engineering
SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.
Better Bioprinting by Light-sheet Lithography
B-BRIGHTER aims to develop a novel high-speed bioprinting technology for creating complex engineered tissues, enhancing drug testing and therapeutic applications while fostering healthcare innovation.
3D voedselprinters op weg naar industriële toepassingen
Het project ontwikkelt een industriële 3D voedselprinter voor het produceren van hoogwaardige, gezonde en betaalbare vlees- en visvervangers met authentieke textuur en hoge productiesnelheid.